Veraxa Biotech Holding AG (VRXAW) Current Assets (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Current Assets of $3.6 million for Q4 2025, down 43.61% year-over-year from $6.4 million in Q4 2024, and down 43.61% quarter-over-quarter from $6.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Current Assets (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Current Assets for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 43.61% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (down 43.61% YoY), while the FY2025 annual figure was $3.6 million, down 43.61% from the prior year.
- Current Assets slipped to $3.6 million in Q4 2025 per VRXAW's latest filing, from $6.4 million in the prior quarter.
- Across five years, Current Assets topped out at $6.4 million in Q4 2024 and bottomed at $3.6 million in Q4 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 6.40 Mn |